APA

Sommerer C., Suwelack B., Dragun D., Schenker P., Hauser I. A., Nashan B. & Thaiss F. (20161213). Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. : Trials.

Chicago

Sommerer Claudia, Suwelack Barbara, Dragun Duska, Schenker Peter, Hauser Ingeborg A, Nashan Björn and Thaiss Friedrich. 20161213. Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. : Trials.

Harvard

Sommerer C., Suwelack B., Dragun D., Schenker P., Hauser I. A., Nashan B. and Thaiss F. (20161213). Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. : Trials.

MLA

Sommerer Claudia, Suwelack Barbara, Dragun Duska, Schenker Peter, Hauser Ingeborg A, Nashan Björn and Thaiss Friedrich. Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. : Trials. 20161213.